Country: United States
Language: English
Source: NLM (National Library of Medicine)
Zinc Oxide 15%
Davion, Inc.
TOPICAL
OTC DRUG
Skin Protectant - Skin Protectant - Dries the oozing and weeping of poison - Ivy - Oak - Sumac
OTC monograph final
PROTECTIVE POWDER- ZINC OXIDE POWDER DAVION, INC. ---------- DRUG FACTS ACTIVE INGREDIENTS Zinc Oxide 15% PURPOSE Skin Protectant USES Skin Protectant Dries the oozing and weeping of poison Ivy Oak Sumac _WARNINGS_ FOR EXTERNAL USE ONLY. WHEN USING THIS PRODUCT Do not get into eyes STOP USE AND ASK A DOCTOR if condition worsens symptoms last more than 7 days or clear up and occur again within a few days KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away. _DIRECTIONS_ Apply as needed _INACTIVE INGREDIENTS_ Zea Mays (Corn) Starch, Tricalcium Phosphate, Calcium Stearate, Fragrance PRINCIPAL DISPLAY PANEL CVS Health Fresh Scent PROTECTIVE POWDER SKIN PROTECTANT ZINC OXIDE For babies & adults Helps protect chafed/irritated skin Absorbs moisture Talc free NET WT 5 OZ (142g) PROTECTIVE POWDER zinc oxide powder PRODUCT INFORMATION PRODUCT TYPE HUMAN OTC DRUG ITEM CODE (SOURCE) NDC:42669-233 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY Davion, Inc. INGREDIENT NAME BASIS OF STRENGTH STRENGTH ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 15 g in 142 g INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH TRICALCIUM PHOSPHATE (UNII: K4C08XP666) ZEA MAYS SUBSP. MAYS WHOLE (UNII: 1G5HNE09V8) CALCIUM STEARATE (UNII: 776XM7047L) PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:42669-233- 01 142 g in 1 BOX; Type 0: Not a Combination Product 01/10/2017 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE OTC Monograph Drug M017 01/10/2017 LABELER - Davion, Inc. (174542928) REGISTRANT - Davion, Inc (079536689) ESTABLISHMENT NAME ADDRESS ID/FEI BUSINESS OPERATIONS Davion, Inc 079536689 manufacture(42669-233) Revised: 2/2024 Read the complete document